返回
bioMérieux S.A.（BMXMF）價格
BMXMF 股價走勢圖
BMXMF 收益
bioMérieux S.A.
$121.32
-2.99%
$-3.74
收盤價：Jan 20, 16:00:00 GMT-5
$121.32
0%
$0
盤後：Jan 20, 17:26:29 GMT-5
關鍵數據
前收市價
$125.06
開盤價
$121.32
當日範圍
$121.32 - $121.32
52週區間
$116 - $152
交易量
2
平均成交量
46
每股盈餘 (TTM)
3.69
股息收益率
--
市值
$14.3B
什麼是 Biomerieux 69 Marcy L'Etoile？
bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. The company is headquartered in Craponne, Auvergne-Rhone-Alpes and currently employs 14,754 full-time employees. The company went IPO on 2004-06-07. The firm designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The firm also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.